SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

TCS, Strides Pharma Science and Ashoka Buildcon to see some action today

Thirumalai Chemicals Ltd. | Chemicals | Chemicals & Fertilizers | BSE: 500412 | NSE: TIRUMALCHM

28 May 2021 Evaluate

Tata Consultancy Services (TCS) has completed the acquisition of GE's stake in Tata Consultancy Services Saudi Arabia for $12,471 (about Rs 9.13 lakh). In September 2013, TCS had announced the creation of an all-women business process services centre in Riyadh (Saudi Arabia) in partnership with GE. In January, TCS had said it will assume full responsibility of the centre upon completion of the required governance and business changes to effect this transition. This, it had said, would secure the centre's viability in the longer term and allow it to continue to serve as a source of opportunity and skills development for women in the country.

Strides Pharma Science and Taiwan-based specialty pharmaceutical firm TLC have partnered to launch Liposomal Amphotericin B, a drug used in the treatment of mucormycosis (black fungus), in India. The Central Drugs Standard Control Organization (CDSCO) has approved TLC's new drug application (NDA) of Amphotericin B Liposome for Injection 50mg in India for immediate importation per approved usage and indication.

Ashoka Buildcon has received Letter of Acceptance from Fahi Dhiriulhun Corporation, a State-owned company of the Government of the Republic of the Maldives, for the Project viz. 'Design and Construction of 2000 Social Housing Units in Hulhumale', Republic of Maldives' 'Project) on Engineering, Procurement and Construction (EPC) basis. The total value for this project is estimated to be around $140.33 Million (Rs 1018.36 crore).

Infibeam Avenues has received approval to make further investment in Avenues Payments India. The objective of investment is increasing the cross-border E-commerce Business transactions and making the remittance business cash free through fin-tech solutions.

Innovators Facade Systems has received work order of approximately Rs 45 crore for design, supply, fabrication and installation of facade work in Mumbai from Glider Buildcon Realtors.

Thirumalai Chemicals is planning to execute a project to manufacture 180,000 tons per year of Phthalic Anhydride (PA) and 30,000 tons per year of Fine & Specialty Chemicals, at its existing site at Dahej, Gujarat, and Western India - to be implemented in two successive phases. The company expects to bring the first of these two phases on-stream in about 2 years after receipt of all needed approvals.

NLC India has raised Rs 300 crore through Commercial Paper and allotted 6000 Nos. of Commercial Paper of a face value of Rs 5 lakh each on May 27, 2021.

Thirumalai Chemicals Share Price

200.60 -1.40 (-0.69%)

17-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
BASF India	3703.10
Tata Chemicals	709.05
SRF	2493.65
Pidilite Inds.	1393.25
Deepak Nitrite	1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

TCS, Strides Pharma Science and Ashoka Buildcon to see some action today

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.